• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Vpu 直接结合 tetherin 并将其从新生成的病毒粒子中置换出来。

Vpu binds directly to tetherin and displaces it from nascent virions.

机构信息

Howard Hughes Medical Institute, Aaron Diamond AIDS Research Center and Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.

出版信息

PLoS Pathog. 2013;9(4):e1003299. doi: 10.1371/journal.ppat.1003299. Epub 2013 Apr 25.

DOI:10.1371/journal.ppat.1003299
PMID:23633949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3635990/
Abstract

Tetherin (Bst2/CD317/HM1.24) is an interferon-induced antiviral host protein that inhibits the release of many enveloped viruses by tethering virions to the cell surface. The HIV-1 accessory protein, Vpu, antagonizes Tetherin through a variety of proposed mechanisms, including surface downregulation and degradation. Previous studies have demonstrated that mutation of the transmembrane domains (TMD) of both Vpu and Tetherin affect antagonism, but it is not known whether Vpu and Tetherin bind directly to each other. Here, we use cysteine-scanning mutagenesis coupled with oxidation-induced cross-linking to demonstrate that Vpu and Tetherin TMDs bind directly to each other in the membranes of living cells and to map TMD residues that contact each other. We also reveal a property of Vpu, namely the ability to displace Tetherin from sites of viral assembly, which enables Vpu to exhibit residual Tetherin antagonist activity in the absence of surface downregulation or degradation. Elements in the cytoplasmic tail domain (CTD) of Vpu mediate this displacement activity, as shown by experiments in which Vpu CTD fragments were directly attached to Tetherin in the absence of the TMD. In particular, the C-terminal α-helix (H2) of Vpu CTD is sufficient to remove Tetherin from sites of viral assembly and is necessary for full Tetherin antagonist activity. Overall, these data demonstrate that Vpu and Tetherin interact directly via their transmembrane domains enabling activities present in the CTD of Vpu to remove Tetherin from sites of viral assembly.

摘要

tetherin(Bst2/CD317/HM1.24)是一种干扰素诱导的抗病毒宿主蛋白,通过将病毒颗粒 tetherin 固定在细胞表面来抑制许多包膜病毒的释放。HIV-1 辅助蛋白 Vpu 通过多种提出的机制拮抗 tetherin,包括表面下调和降解。先前的研究表明,Vpu 和 tetherin 的跨膜结构域(TMD)突变会影响拮抗作用,但尚不清楚 Vpu 和 tetherin 是否直接相互结合。在这里,我们使用半胱氨酸扫描突变结合氧化诱导交联来证明 Vpu 和 tetherin TMD 在活细胞的膜中直接相互结合,并绘制相互接触的 TMD 残基。我们还揭示了 Vpu 的一个特性,即能够从病毒组装部位置换 tetherin,这使得 Vpu 在没有表面下调或降解的情况下仍然具有残留的 tetherin 拮抗活性。Vpu 细胞质尾域(CTD)中的元件介导了这种置换活性,这可以通过实验证明,其中 Vpu CTD 片段在没有 TMD 的情况下直接连接到 tetherin。特别是,Vpu CTD 的 C 末端α螺旋(H2)足以将 tetherin 从病毒组装部位移除,并且是完全的 tetherin 拮抗活性所必需的。总的来说,这些数据表明,Vpu 和 tetherin 通过它们的跨膜结构域直接相互作用,使得 Vpu CTD 中的活性能够将 tetherin 从病毒组装部位移除。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/98ecad6df2ea/ppat.1003299.g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/5de1289ec48e/ppat.1003299.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/f3a7847db21c/ppat.1003299.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/9de5b2b7b4f5/ppat.1003299.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/204ba51364c0/ppat.1003299.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/44bbcc064af8/ppat.1003299.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/73fd4460fcf9/ppat.1003299.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/2cffa3af4f75/ppat.1003299.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/8e58efb68631/ppat.1003299.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/d1d75d9da846/ppat.1003299.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/db49c155f4a7/ppat.1003299.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/c2e76c30ee8f/ppat.1003299.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/1028975def3d/ppat.1003299.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/98ecad6df2ea/ppat.1003299.g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/5de1289ec48e/ppat.1003299.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/f3a7847db21c/ppat.1003299.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/9de5b2b7b4f5/ppat.1003299.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/204ba51364c0/ppat.1003299.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/44bbcc064af8/ppat.1003299.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/73fd4460fcf9/ppat.1003299.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/2cffa3af4f75/ppat.1003299.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/8e58efb68631/ppat.1003299.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/d1d75d9da846/ppat.1003299.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/db49c155f4a7/ppat.1003299.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/c2e76c30ee8f/ppat.1003299.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/1028975def3d/ppat.1003299.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c993/3635990/98ecad6df2ea/ppat.1003299.g013.jpg

相似文献

1
Vpu binds directly to tetherin and displaces it from nascent virions.Vpu 直接结合 tetherin 并将其从新生成的病毒粒子中置换出来。
PLoS Pathog. 2013;9(4):e1003299. doi: 10.1371/journal.ppat.1003299. Epub 2013 Apr 25.
2
HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.HIV-1病毒蛋白U通过衔接蛋白1介导的排除作用,使其不参与病毒组装位点,从而拮抗CD317/束缚素。
J Virol. 2016 Jul 11;90(15):6709-6723. doi: 10.1128/JVI.00504-16. Print 2016 Aug 1.
3
A cytoplasmic tail determinant in HIV-1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction.HIV-1 Vpu 中的细胞质尾巴决定簇介导 tetherin 的靶向内体降解,并拮抗干扰素诱导的限制。
PLoS Pathog. 2012;8(3):e1002609. doi: 10.1371/journal.ppat.1002609. Epub 2012 Mar 29.
4
Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity.HIV-1 Vpu 跨膜区核心的极性变化抑制其抗 tetherin 活性。
PLoS One. 2011;6(6):e20890. doi: 10.1371/journal.pone.0020890. Epub 2011 Jun 2.
5
Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.人免疫缺陷病毒 1 型 Vpu 蛋白跨膜结构域中抑制 tetherin 的决定因素。
J Virol. 2010 Dec;84(24):12958-70. doi: 10.1128/JVI.01699-10. Epub 2010 Oct 6.
6
The C-Terminal End of HIV-1 Vpu Has a Clade-Specific Determinant That Antagonizes BST-2 and Facilitates Virion Release.HIV-1 Vpu 的 C 端末端具有一种特定于进化枝的决定簇,可拮抗 BST-2 并促进病毒粒子释放。
J Virol. 2019 May 15;93(11). doi: 10.1128/JVI.02315-18. Print 2019 Jun 1.
7
Filamin A Is Involved in HIV-1 Vpu-mediated Evasion of Host Restriction by Modulating Tetherin Expression.细丝蛋白A通过调节束缚素表达参与HIV-1 Vpu介导的宿主限制逃避。
J Biol Chem. 2016 Feb 19;291(8):4236-46. doi: 10.1074/jbc.M115.708123. Epub 2016 Jan 7.
8
Membrane Anchoring by a C-terminal Tryptophan Enables HIV-1 Vpu to Displace Bone Marrow Stromal Antigen 2 (BST2) from Sites of Viral Assembly.通过C末端色氨酸进行膜锚定可使HIV-1 Vpu从病毒组装位点取代骨髓基质抗原2(BST2)。
J Biol Chem. 2015 Apr 24;290(17):10919-33. doi: 10.1074/jbc.M114.630095. Epub 2015 Mar 10.
9
Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1.HIV-1病毒蛋白U(Vpu)通过劫持网格蛋白衔接蛋白复合物1介导的BST2拮抗作用的结构基础
Elife. 2014 Apr 29;3:e02362. doi: 10.7554/eLife.02362.
10
β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release.β-TrCP 对于 Vpu 克服 CD317/Tetherin 对 HIV-1 释放的限制的能力是可有可无的。
Retrovirology. 2011 Feb 10;8:9. doi: 10.1186/1742-4690-8-9.

引用本文的文献

1
Advances in Viroporin Function and Structure: A Comparative Analysis of Alphavirus 6K with Well-Characterized Viroporins.病毒孔蛋白功能与结构的进展:甲病毒6K与特征明确的病毒孔蛋白的比较分析
Viruses. 2025 Jun 19;17(6):868. doi: 10.3390/v17060868.
2
Adaptor Protein Complexes in HIV-1 Pathogenesis: Mechanisms and Therapeutic Potential.HIV-1发病机制中的衔接蛋白复合体:作用机制与治疗潜力
Viruses. 2025 May 16;17(5):715. doi: 10.3390/v17050715.
3
The Deubiquitinase OTUD1 Influences HIV-1 Release by Regulating the Host Restriction Factor BST-2.

本文引用的文献

1
A cytoplasmic tail determinant in HIV-1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction.HIV-1 Vpu 中的细胞质尾巴决定簇介导 tetherin 的靶向内体降解,并拮抗干扰素诱导的限制。
PLoS Pathog. 2012;8(3):e1002609. doi: 10.1371/journal.ppat.1002609. Epub 2012 Mar 29.
2
Ubiquitination of BST-2 protein by HIV-1 Vpu protein does not require lysine, serine, or threonine residues within the BST-2 cytoplasmic domain.HIV-1 Vpu 蛋白对 BST-2 蛋白的泛素化作用不需要 BST-2 细胞质结构域内的赖氨酸、丝氨酸或苏氨酸残基。
J Biol Chem. 2012 Apr 27;287(18):14837-50. doi: 10.1074/jbc.M112.349928. Epub 2012 Mar 1.
3
去泛素化酶OTUD1通过调控宿主限制因子BST-2影响HIV-1释放。
Viruses. 2025 Feb 14;17(2):260. doi: 10.3390/v17020260.
4
piRNA Defense Against Endogenous Retroviruses.piRNA对内源逆转录病毒的防御作用
Viruses. 2024 Nov 9;16(11):1756. doi: 10.3390/v16111756.
5
Antagonism of BST2/Tetherin, a new restriction factor of respiratory syncytial virus, requires the viral NS1 protein.呼吸道合胞病毒的一种新限制因子BST2/栓系蛋白的拮抗作用需要病毒NS1蛋白。
PLoS Pathog. 2024 Nov 19;20(11):e1012687. doi: 10.1371/journal.ppat.1012687. eCollection 2024 Nov.
6
Metformin facilitates viral reservoir reactivation and their recognition by anti-HIV-1 envelope antibodies.二甲双胍促进病毒储存库的重新激活及其被抗HIV-1包膜抗体识别。
iScience. 2024 Aug 5;27(9):110670. doi: 10.1016/j.isci.2024.110670. eCollection 2024 Sep 20.
7
Metformin Enhances Antibody-Mediated Recognition of HIV-Infected CD4 T-Cells by Decreasing Viral Release.二甲双胍通过减少病毒释放增强抗体介导的对HIV感染的CD4 T细胞的识别。
bioRxiv. 2024 Feb 19:2024.02.15.580166. doi: 10.1101/2024.02.15.580166.
8
Ubiquitin-Dependent and Independent Proteasomal Degradation in Host-Pathogen Interactions.宿主-病原体相互作用中泛素依赖性和非依赖性蛋白酶体降解
Molecules. 2023 Sep 21;28(18):6740. doi: 10.3390/molecules28186740.
9
ATG5 selectively engages virus-tethered BST2/tetherin in an LC3C-associated pathway.ATG5 通过 LC3C 相关途径选择性地与病毒结合的 BST2/ tetherin 结合。
Proc Natl Acad Sci U S A. 2023 May 16;120(20):e2217451120. doi: 10.1073/pnas.2217451120. Epub 2023 May 8.
10
Requirement of a functional ion channel for Sindbis virus glycoprotein transport, CPV-II formation, and efficient virus budding.功能性离子通道对于辛德毕斯病毒糖蛋白运输、CPV-II 形成和高效病毒出芽的需求。
PLoS Pathog. 2022 Oct 3;18(10):e1010892. doi: 10.1371/journal.ppat.1010892. eCollection 2022 Oct.
HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions.
HIV-1 Vpu 蛋白通过脂质嵌入的螺旋-螺旋相互作用拮抗先天限制因子 BST-2。
J Biol Chem. 2012 Jan 2;287(1):58-67. doi: 10.1074/jbc.M111.296772. Epub 2011 Nov 9.
4
Separable determinants of subcellular localization and interaction account for the inability of group O HIV-1 Vpu to counteract tetherin. 细胞内定位和相互作用的可分离决定因素解释了 O 组 HIV-1 Vpu 无法拮抗 tetherin 的原因。
J Virol. 2011 Oct;85(19):9737-48. doi: 10.1128/JVI.00479-11. Epub 2011 Jul 20.
5
SIV Nef proteins recruit the AP-2 complex to antagonize Tetherin and facilitate virion release.SIV Nef 蛋白募集 AP-2 复合物拮抗 tetherin 并促进病毒粒子释放。
PLoS Pathog. 2011 May;7(5):e1002039. doi: 10.1371/journal.ppat.1002039. Epub 2011 May 19.
6
HIV-1 Vpu blocks recycling and biosynthetic transport of the intrinsic immunity factor CD317/tetherin to overcome the virion release restriction.HIV-1 Vpu 阻断固有免疫因子 CD317/ tetherin 的回收和生物合成运输,以克服病毒释放的限制。
mBio. 2011 May 24;2(3):e00036-11. doi: 10.1128/mBio.00036-11. Print 2011.
7
Tetherin inhibits prototypic foamy virus release.Tetherin 抑制原型泡沫病毒的释放。
Virol J. 2011 May 2;8:198. doi: 10.1186/1743-422X-8-198.
8
Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection.猫 tetherin 可有效地限制猫免疫缺陷病毒的释放,但不能阻止感染的传播。
J Virol. 2011 Jun;85(12):5840-52. doi: 10.1128/JVI.00071-11. Epub 2011 Apr 13.
9
PCR Mutagenesis by Overlap Extension and Gene SOE.通过重叠延伸和基因拼接进行PCR诱变
CSH Protoc. 2008 Feb 1;2008:pdb.prot4861. doi: 10.1101/pdb.prot4861.
10
β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release.β-TrCP 对于 Vpu 克服 CD317/Tetherin 对 HIV-1 释放的限制的能力是可有可无的。
Retrovirology. 2011 Feb 10;8:9. doi: 10.1186/1742-4690-8-9.